Clinical Trial Update: A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety and efficacy of a novel patch infusor device combined with a subcutaneous furosemide formulation in patients with heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Lasix (furosemide) (furosemide)

Snippet

Sponsor: SQ Innovation, Inc. | Conditions: Heart Failure | Phase 1 | Status: COMPLETED | Results posted: 2026-04-24